» Articles » PMID: 37941648

Clear Cell Renal Cell Carcinoma with Mutation: a Report of Two Cases

Overview
Specialty Urology
Date 2023 Nov 9
PMID 37941648
Authors
Affiliations
Soon will be listed here.
Abstract

Clear cell renal cell carcinoma is the most common subtype of renal cell carcinomas (RCCs) and accounts for 60%-70% of all RCCs cases in adults. Aberrations in the von Hippel-Lindau () gene on chromosome 3p occurred in > 90% of clear cell RCCs. Other tumor suppressor genes located on chromosome 3p, such as , and , also contribute to tumorigenesis. Clear cell RCCs with both and mutations may display distinctive histopathological features. Here, we report two cases of clear cell RCCs with mutation. One tumor had , and mutations and the tumor nests and alveoli of tumor cells were surrounded by proliferative vessels and the optically clear cytoplasm contained numerous eosinophilic granules and hyaline globules of varying sizes. The other tumor had and mutations, and demonstrated clear cells with numerous eosinophilic granules and other typical histopathological features of conventional clear cell RCC. Furthermore, many tumor nodules with dense peripheral lymphocytic infiltrates contained rhabdoid cells. Sarcomatoid cells were also observed. Both tumor cells showed high-grade nuclei. Clear cell RCCs with mutation exhibit aggressive clinical behaviors.

Citing Articles

Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

George T, Lee J, DeRemer D, Hosein P, Staal S, Markham M JCO Precis Oncol. 2024; 8:e2400406.

PMID: 39626160 PMC: 11616782. DOI: 10.1200/PO-24-00406.

References
1.
Sangoi A, Karamchandani J, Kim J, Pai R, McKenney J . The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10. Adv Anat Pathol. 2010; 17(6):377-93. DOI: 10.1097/PAP.0b013e3181f89400. View

2.
Nickerson M, Jaeger E, Shi Y, Durocher J, Mahurkar S, Zaridze D . Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res. 2008; 14(15):4726-34. PMC: 2629664. DOI: 10.1158/1078-0432.CCR-07-4921. View

3.
Mejean A, Ravaud A, Thezenas S, Colas S, Beauval J, Bensalah K . Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2018; 379(5):417-427. DOI: 10.1056/NEJMoa1803675. View

4.
Liu Y, Li Y, Xu H, Zhou L, Yang X, Wang C . Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With , , , or Mutations. Int J Surg Pathol. 2023; 31(8):1485-1494. DOI: 10.1177/10668969231157317. View

5.
Yang B, Duan H, Cao W, Guo Y, Liu Y, Sun L . Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis. Mod Pathol. 2019; 32(10):1521-1535. DOI: 10.1038/s41379-019-0283-z. View